Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |